Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials

Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychopharmacology (New York, N.Y.) N.Y.), 2020-04, Vol.45 (5), p.902-902
Hauptverfasser: Tani, Hideaki, Takasu, Shotaro, Uchida, Hiroyuki, Suzuki, Takefumi, Mimura, Masaru, Takeuchi, Hiroyoshi
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 902
container_issue 5
container_start_page 902
container_title Neuropsychopharmacology (New York, N.Y.)
container_volume 45
creator Tani, Hideaki
Takasu, Shotaro
Uchida, Hiroyuki
Suzuki, Takefumi
Mimura, Masaru
Takeuchi, Hiroyoshi
description An amendment to this paper has been published and can be accessed via a link at the top of the paper.
doi_str_mv 10.1038/s41386-019-0598-y
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7265365</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2476738509</sourcerecordid><originalsourceid>FETCH-LOGICAL-c252y-5379056e12d9972d51d9ba013a060f69ec197b64e42d7fb943d84a59fd83099d3</originalsourceid><addsrcrecordid>eNp9ksGKFDEQhoMo7jj6AF4k4MVLa9JJdzp7EGRwVVjworC3kEmqnSzdSZukZ-l9PJ_MtLMu6kEIVEi-v6pS-RF6TslrSlj3JnHKurYiVFakkV21PEAbKjipWsavHqIN6SSrKGNXZ-hJSteE0Ea03WN0xqgUnPN6g37sQoxgsgv-HF9ok0NMWKcUjNMZLL5x-YDTbAyk1M8D1j67KS3mELIz2IYEOIKdfyXAzuNkDu42TIcI3ulzrHFaUoZRr3SEo4MbHHo8xZCmteoRsBmcd0YPOEenh1LcWzxC1pX2eliSS6sgltMwutvSkQk-xzAMZXtSPEWP-hLg2V3coq8X77_sPlaXnz982r27rEzd1EvVMCFJ0wKtrZSitg21cq8JZZq0pG8lmDKUfcuB11b0e8mZ7bhuZG87RqS0bIvenvJO834Ea6D0oQc1RTfquKignfr7xruD-haOStRtw8raold3CWL4PkPKanTJwDBoD2FOqmblS4QgvC7oy3_Q6zDHMpBCcdEK1jVE_pdiomBUNKJQ9ESZMvUUob9vmRK1-kidfKSKj9TqI7UUzYs_33qv-G0c9hN1dMoI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2377671757</pqid></control><display><type>article</type><title>Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials</title><source>SpringerLink_现刊</source><source>Free E-Journal (出版社公開部分のみ）</source><source>PubMed Central</source><creator>Tani, Hideaki ; Takasu, Shotaro ; Uchida, Hiroyuki ; Suzuki, Takefumi ; Mimura, Masaru ; Takeuchi, Hiroyoshi</creator><creatorcontrib>Tani, Hideaki ; Takasu, Shotaro ; Uchida, Hiroyuki ; Suzuki, Takefumi ; Mimura, Masaru ; Takeuchi, Hiroyoshi</creatorcontrib><description>An amendment to this paper has been published and can be accessed via a link at the top of the paper.</description><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>DOI: 10.1038/s41386-019-0598-y</identifier><identifier>PMID: 31974442</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><ispartof>Neuropsychopharmacology (New York, N.Y.), 2020-04, Vol.45 (5), p.902-902</ispartof><rights>2020© The Author(s), under exclusive licence to American College of Neuropsychopharmacology 2020</rights><rights>The Author(s), under exclusive licence to American College of Neuropsychopharmacology 2020.</rights><rights>The Author(s), under exclusive licence to American College of Neuropsychopharmacology 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-8844-4786 ; 0000-0002-5147-1684 ; 0000-0002-0628-7036</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265365/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265365/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31974442$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tani, Hideaki</creatorcontrib><creatorcontrib>Takasu, Shotaro</creatorcontrib><creatorcontrib>Uchida, Hiroyuki</creatorcontrib><creatorcontrib>Suzuki, Takefumi</creatorcontrib><creatorcontrib>Mimura, Masaru</creatorcontrib><creatorcontrib>Takeuchi, Hiroyoshi</creatorcontrib><title>Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials</title><title>Neuropsychopharmacology (New York, N.Y.)</title><addtitle>Neuropsychopharmacology</addtitle><description>An amendment to this paper has been published and can be accessed via a link at the top of the paper.</description><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9ksGKFDEQhoMo7jj6AF4k4MVLa9JJdzp7EGRwVVjworC3kEmqnSzdSZukZ-l9PJ_MtLMu6kEIVEi-v6pS-RF6TslrSlj3JnHKurYiVFakkV21PEAbKjipWsavHqIN6SSrKGNXZ-hJSteE0Ea03WN0xqgUnPN6g37sQoxgsgv-HF9ok0NMWKcUjNMZLL5x-YDTbAyk1M8D1j67KS3mELIz2IYEOIKdfyXAzuNkDu42TIcI3ulzrHFaUoZRr3SEo4MbHHo8xZCmteoRsBmcd0YPOEenh1LcWzxC1pX2eliSS6sgltMwutvSkQk-xzAMZXtSPEWP-hLg2V3coq8X77_sPlaXnz982r27rEzd1EvVMCFJ0wKtrZSitg21cq8JZZq0pG8lmDKUfcuB11b0e8mZ7bhuZG87RqS0bIvenvJO834Ea6D0oQc1RTfquKignfr7xruD-haOStRtw8raold3CWL4PkPKanTJwDBoD2FOqmblS4QgvC7oy3_Q6zDHMpBCcdEK1jVE_pdiomBUNKJQ9ESZMvUUob9vmRK1-kidfKSKj9TqI7UUzYs_33qv-G0c9hN1dMoI</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Tani, Hideaki</creator><creator>Takasu, Shotaro</creator><creator>Uchida, Hiroyuki</creator><creator>Suzuki, Takefumi</creator><creator>Mimura, Masaru</creator><creator>Takeuchi, Hiroyoshi</creator><general>Nature Publishing Group</general><general>Springer International Publishing</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8844-4786</orcidid><orcidid>https://orcid.org/0000-0002-5147-1684</orcidid><orcidid>https://orcid.org/0000-0002-0628-7036</orcidid></search><sort><creationdate>202004</creationdate><title>Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials</title><author>Tani, Hideaki ; Takasu, Shotaro ; Uchida, Hiroyuki ; Suzuki, Takefumi ; Mimura, Masaru ; Takeuchi, Hiroyoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c252y-5379056e12d9972d51d9ba013a060f69ec197b64e42d7fb943d84a59fd83099d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tani, Hideaki</creatorcontrib><creatorcontrib>Takasu, Shotaro</creatorcontrib><creatorcontrib>Uchida, Hiroyuki</creatorcontrib><creatorcontrib>Suzuki, Takefumi</creatorcontrib><creatorcontrib>Mimura, Masaru</creatorcontrib><creatorcontrib>Takeuchi, Hiroyoshi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tani, Hideaki</au><au>Takasu, Shotaro</au><au>Uchida, Hiroyuki</au><au>Suzuki, Takefumi</au><au>Mimura, Masaru</au><au>Takeuchi, Hiroyoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><addtitle>Neuropsychopharmacology</addtitle><date>2020-04</date><risdate>2020</risdate><volume>45</volume><issue>5</issue><spage>902</spage><epage>902</epage><pages>902-902</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><abstract>An amendment to this paper has been published and can be accessed via a link at the top of the paper.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>31974442</pmid><doi>10.1038/s41386-019-0598-y</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-8844-4786</orcidid><orcidid>https://orcid.org/0000-0002-5147-1684</orcidid><orcidid>https://orcid.org/0000-0002-0628-7036</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-133X
ispartof Neuropsychopharmacology (New York, N.Y.), 2020-04, Vol.45 (5), p.902-902
issn 0893-133X
1740-634X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7265365
source SpringerLink_现刊; Free E-Journal (出版社公開部分のみ）; PubMed Central
title Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A00%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction:%20Factors%20associated%20with%20successful%20antipsychotic%20dose%20reduction%20in%20schizophrenia:%20a%20systematic%20review%20of%20prospective%20clinical%20trials%20and%20meta-analysis%20of%20randomized%20controlled%20trials&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=Tani,%20Hideaki&rft.date=2020-04&rft.volume=45&rft.issue=5&rft.spage=902&rft.epage=902&rft.pages=902-902&rft.issn=0893-133X&rft.eissn=1740-634X&rft_id=info:doi/10.1038/s41386-019-0598-y&rft_dat=%3Cproquest_pubme%3E2476738509%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2377671757&rft_id=info:pmid/31974442&rfr_iscdi=true